Navigation Links
Enzymatics Honored With a Top 10 Small Business of the Year Award
Date:8/2/2011

BEVERLY, Mass., Aug. 2, 2011 /PRNewswire/ -- Enzymatics, Inc., (www.enzymatics.com) a leading biotech manufacturing company, has been honored by the Greater Boston Chamber of Commerce with a "Top 10 Small Business" of the year award for 2011.

Honorees include dynamic small and high growth businesses in Greater Boston that have demonstrated strong financial performance, workplace excellence, product innovation, and social responsibility.  An awards luncheon will be held to honor these businesses October 13, 2011 at the Colonnade Hotel in Boston, MA.

"We've seen incredible growth in just five short years, and that comes from a lot of hard work," said Enzymatics co-founder and president Christopher Benoit.  "It's a great boost for our team to receive this award and have their dedication and innovation recognized."

As of this summer, the Beverly-based biotech firm was in the process of expanding its headquarters, opening a European office, and adding 15 new full-time positions to its existing staff of 50.

Beyond employee contributions, co-founder and CEO Stephen Picone gives a nod to the region's biotech community for helping foster company success:  "Thanks to sound investment, good policy, and all the forward-thinking business leaders that operate in our space, Massachusetts has become an international center for biotech manufacturing.  This has been an ideal place for us to do business, and we'd like to thank all our customers and the regional partners who helped fuel our growth."

The Chamber's Small Business of the Year Awards is now in its 27th year of recognizing the achievements of the top ten businesses. "The 2011 winners are an excellent representation of the entrepreneurial spirit, focus on excellence and commitment to the community that define our region's small businesses," said Paul Guzzi, president and CEO of the Greater Boston Chamber of Commerce. "We look forward to honoring them."

ABOUT ENZYMATICS: Enzymatics is a leading biotechnology and biosciences manufacturing company that delivers ISO 13485-compliant enzymes of unrivaled purity, consistency, and value to the healthcare and bioscience industries. Headquartered in Beverly, Massachusetts, the company adheres to a customer-as-partner business model and also leverages key institutional licensing agreements in order to commercialize breakthrough biotechnologies.  Enzymatics currently ships products to over 20 countries.  For more information please visit www.enzymatics.com.

Contact: Lisa Lazarczyk, lazPR
781-646-0667/lisa@lazpr.com


'/>"/>
SOURCE Enzymatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
2. NeoStem Chairman and CEO to be Honored at the Moves 2010 Power Women Awards
3. OU professor honored for excellence in chemistry
4. MicroCHIPS Honored With 2010 Edison Best New Product Award
5. Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award
6. LaVoie Group Honored by LACP with Two Awards
7. CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content
8. Researcher honored for experimental work in nanotechnology
9. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
10. Booshoot Founder & CEO Jackie Heinricher Honored as Visionary Entrepreneur by Martha Stewart
11. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) a ... Research . GGI's mission is to advance global health and highlight the greater good ... honor of each clinical trial volunteer. The vision of GGI is to serve as ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
Breaking Biology News(10 mins):